Literature DB >> 1385152

Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens.

T Defrance1, B Vanbervliet, I Durand, J Briolay, J Banchereau.   

Abstract

The pan-T cell antigen CD5 has been shown to delineate two different mouse B cell subsets, originating from distinct progenitors. In man, on average, 30% of the tonsillar B cell pool expresses this antigen. In the present report, a detailed comparison of the CD5+ and CD5- B cell response to cytokines, following activation via surface immunoglobulins (sIg) or CD40 antigen, was undertaken. CD5+ B cells were positively selected by panning or by sorting from tonsils. Two-color immunofluorescence analysis performed on tonsillar B cell populations showed that CD5+ B cells displayed most of the phenotypic features of mantle zone B cells. CD5+ B cells could be stimulated for DNA synthesis by mitogenic concentrations of Staphylococcus aureus, Cowan I strain (SAC), insolubilized anti-IgM antibodies, immobilized anti-CD40 antibodies and phorbol 12-myristate 13-acetate (PMA). The growth-response of small dense CD5- B cells to these T cell-independent mitogens was comparable to that of CD5+ B cells, whereas the low-density, in vivo-activated, CD5- B cells were only marginally stimulated by Ig-cross-linking agents and PMA. Following ligation of sIg, both B cell subsets proliferated essentially in response to interleukin (IL)-2 and IL-4. When used in co-stimulation with immobilized anti-CD40 antibodies, IL-4 promoted growth of CD5+ and CD5- B cells, whereas IL-2 displayed only moderate stimulatory effects. CD5+ and CD5- B cells differentiated into Ig-secreting cells when they were co-cultured with SAC or cross-linked anti-CD40 antibodies and IL-2. However, IgM constituted the major component of the Ig response of CD5+ B cells, whereas high levels of IgG were secreted by CD5- B cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385152     DOI: 10.1002/eji.1830221112

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Age-dependent altered proportions in subpopulations of tonsillar lymphocytes.

Authors:  W Bergler; S Adam; H J Gross; K Hörmann; R Schwartz-Albiez
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.

Authors:  N Tsukamoto; N Kobayashi; S Azuma; T Yamamoto; J Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

3.  TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling.

Authors:  T K Ishida; T Tojo; T Aoki; N Kobayashi; T Ohishi; T Watanabe; T Yamamoto; J Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 4.  Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.

Authors:  Walaa Darwiche; Brigitte Gubler; Jean-Pierre Marolleau; Hussein Ghamlouch
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

Review 5.  The Regulatory Effects of MicroRNAs on Tumor Immunity.

Authors:  Yan Lu; Muwen Deng; Kang Wang; Yuanhong Peng; Manzhao Ouyang
Journal:  Biomed Res Int       Date:  2022-07-20       Impact factor: 3.246

6.  Interleukin 13 is a B cell stimulating factor.

Authors:  T Defrance; P Carayon; G Billian; J C Guillemot; A Minty; D Caput; P Ferrara
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

Review 7.  The Costimulatory Pathways and T Regulatory Cells in Ischemia-Reperfusion Injury: A Strong Arm in the Inflammatory Response?

Authors:  Laura de Ramon; Jordi Guiteras; Roser Guiteras; Josep M Cruzado; Josep M Grinyó; Juan Torras
Journal:  Int J Mol Sci       Date:  2018-04-25       Impact factor: 5.923

8.  IL-21 in Conjunction with Anti-CD40 and IL-4 Constitutes a Potent Polyclonal B Cell Stimulator for Monitoring Antigen-Specific Memory B Cells.

Authors:  Fridolin Franke; Greg A Kirchenbaum; Stefanie Kuerten; Paul V Lehmann
Journal:  Cells       Date:  2020-02-13       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.